Edward J. Brady - Concepedia

Author

Edward J. Brady

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Brady, Edward J., EDWARD J. BRADY, Edward Brady, Edward J Brady, Edward J. Brady

Publications

686

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy

About

Edward J. Brady is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	581
2	Biochemistry	10	10	455
3	Health Sciences	5	5	306
4	Natural Sciences	2	2	92
5	Public Health	1	1	32

Edward J. Brady

Publications

672

Citations

H-Index

Page 1

	Year	Citations
Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells Richard Saperstein, Pasquale P. Vicario, H.V. Strout, Biochemistry Intact CellsInsulin ReceptorGlucose UptakeInsulin SignalingMetabolic Syndrome	1989	108
Vanadate Treatment of Streptozotocin Diabetic Rats Restores Expression of the Insulin-Responsive Glucose Transporter in Skeletal Muscle H.V. Strout, Pasquale P. Vicario, Chhabi Biswas, Endocrinology Metabolic SyndromeSkeletal MuscleInsulin-responsive Glucose TransporterMedicineVanadate Treatment	1990	78
Activation of Insulin Signal Transduction Pathway and Anti-diabetic Activity of Small Molecule Insulin Receptor Activators Sajjad A. Qureshi, Victor Ding, Zhihua Li, Journal of Biological Chemistry	2000	67
Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor Joseph Duffy, Brian A. Kirk, Zenon Konteatis, Bioorganic & Medicinal Chemistry Letters BiochemistryFunctional SelectivityMedicineG Protein-coupled ReceptorReceptor (Biochemistry)	2005	57
Approaches to peptidomimetics which serve as surrogates for the cis amide bond: novel disulfide-constrained bicyclic hexapeptide analogs of somatostatic. Stephen F. Brady, William J. Paleveda, Byron H. Arison, Tetrahedron Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	1993	52
Anti-Diabetic Efficacy and Impact on Amino Acid Metabolism of GRA1, a Novel Small-Molecule Glucagon Receptor Antagonist James Mu, Sajjad A. Qureshi, Edward J. Brady, PLoS ONE Amino Acid MetabolismInsulin SignalingMetabolic SyndromeMolecular PharmacologyMetabolic Signaling	2012	50
Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core Dong‐Ming Shen, Edward J. Brady, Mari R. Candelore, Bioorganic & Medicinal Chemistry Letters BiochemistryG Protein-coupled ReceptorMedicineFunctional SelectivityMechanism Of Action	2010	47
Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists Qing Dallas-Yang, Xiaolan Shen, Mathias Z. Strowski, European Journal of Pharmacology HepatologyBiochemistryG Protein-coupled ReceptorMedicineLiver Physiology	2004	40
Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists Dong‐Ming Shen, Fengqi Zhang, Edward J. Brady, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryFunctional SelectivityMedicineNatural Sciences	2005	40
Inhibition of Luteinizing Hormone (LH)-Releasing Hormone-Induced Secretion of LH in Rat Anterior Pituitary Cell Culture by Testosterone without Conversion to 5<i>α</i>-Dihydrotestosterone Tehming Liang, Edward J. Brady, A H Cheung, Endocrinology Pituitary CellsDevelopmental BiologyPituitary GlandEndocrine MechanismGonadotropin Biology	1984	32

Page 1